Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Immunology Diagnosis
9.1K views |
+0 today
 Your new post is loading...
Your new post is loading...
|
Scoop.it!
TREC Towards Health. PerkinElmer is proud to introduce the first commercial TREC screening assay. The assay forms a part of a complete system, CE-marked to a...
Alfredo Corell's insight:
TREC assay to diagnosis SCID (first CE-marked diagnostic kit) 
|
JAMA. 2014;312(7):729-738. doi:10.1001/jama.2014.9132.
link: http://jama.jamanetwork.com/article.aspx?articleid=1896983&resultClick=3
Conclusions and Relevance Newborn screening in 11 programs in the United States identified SCID in 1 in 58 000 infants, with high survival. The usefulness of detection of non-SCID T-cell lymphopenias by the same screening remains to be determined.